Skin necrosis after injection of PEG-interferon alpha2b in an HCV-infected patient.
Sparsa
Agnés
A
Loustaud-Ratti
Véronique
V
Alain
Sophie
S
Liozon
Eric
E
Bédane
Christophe
C
Vidal
Elisabeth
E
D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012867:Skin / Q000473:pathology*; D012871:Skin Diseases / Q000473:pathology / Q000821:virology*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b